Why Leggett & Platt (LEG) Stock Is Up Today
Shares of manufacturing company Leggett & Platt (NYSE:LEG) jumped 29.7% in the afternoon session after the company reported strong first-quarter 2025 results: its revenue was in line with Wall Street'
Why Leggett & Platt (LEG) Stock Is Up Today
Shares of manufacturing company Leggett & Platt (NYSE:LEG) jumped 29.7% in the afternoon session after the company reported strong first-quarter 2025 results: its revenue was in line with Wall Street'
Why NXP Semiconductors (NXPI) Stock Is Down Today
Shares of chip manufacturer NXP Semiconductors (NASDAQ: NXPI) fell 8.6% in the afternoon session after the company reported mixed first-quarter 2025 results: Its inventory levels materially increased,
Why NXP Semiconductors (NXPI) Stock Is Down Today
Shares of chip manufacturer NXP Semiconductors (NASDAQ: NXPI) fell 8.6% in the afternoon session after the company reported mixed first-quarter 2025 results: Its inventory levels materially increased,
Why Is Okta (OKTA) Stock Rocketing Higher Today
Shares of identity management software maker Okta (OKTA) jumped 8.9% in the afternoon session after S&P Dow Jones Indices announced the company would be added to the S&P MidCap 400 before trading open
Stocks set for worst 100 day start since Nixon as Trump injects semi-permanent uncertainty
NEW YORK (Reuters) -President Donald Trump's first 100 days in office, set to deliver the worst start for stocks since former President Richard Nixon's second term in 1973, have stoked volatility acro
Stock market retreat in Trump’s first 100 days is among worst starts for a president in almost a century
In President Joe Biden’s first 100 days, the S&P 500 surged more than 9%. Under Trump, it’s tanked almost 8%.
Regeneron Pharmaceuticals Stock Sinks as Eylea Q1 Sales Trail Estimates
Regeneron Pharmaceuticals stock was among the biggest S&P 500 and Nasdaq decliners Tuesday after the biotech firm reported first-quarter sales—especially those of its key Eylea eye disease drug—th
Trump’s tariffs fueled unhealthy uncertainty, but soon markets will ‘settle down,’ says Goldman CEO David Solomon
CEOs are tightening their belts because of the current market uncertainty, Solomon said.
Hims & Hers Stock Surges on Wegovy Deal With Novo Nordisk
Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo Nordisk to bring weight-loss drug Wegovy to its customers.